Squamous Cell Carcinomas in 2 Patients with Diffuse Scleroderma Treated with Mycophenolate Mofetil

@article{Gulamhusein2009SquamousCC,
  title={Squamous Cell Carcinomas in 2 Patients with Diffuse Scleroderma Treated with Mycophenolate Mofetil},
  author={Aliya F Gulamhusein and J. Pope},
  journal={The Journal of Rheumatology},
  year={2009},
  volume={36},
  pages={460 - 461}
}
Systemic sclerosis (SSc) is a rare multisystem connective tissue disease of unclear etiology in which vascular dysfunction, fibrosis of the skin and internal organs, and autoimmunity occur. Until recently, few treatments have been successful at reducing mortality associated with the disease. The use of angiotensin-converting enzyme (ACE) inhibitors and targeted therapies such as endothelin receptor antagonists, prostacyclins, and PDE5 inhibitors have improved outcomes with respect to renal… Expand
Systemic Sclerosis and Malignancy: A Review of Current Data
Novel risk factors related to cancer in scleroderma.
Mechanistic and clinical insights at the scleroderma-cancer interface
Clinical and Pathological Features of Breast Cancer in Systemic Sclerosis: Results from the Sclero-Breast Study

References

SHOWING 1-10 OF 18 REFERENCES
New developments in the pathogenesis of systemic sclerosis
Malignancy after Transplantation
Clinically Relevant Immunosuppressants Influence UVB‐Induced Tumor Size Through Effects on Inflammation and Angiogenesis
  • F. J. Duncan, Brian C. Wulff, +7 authors A. Vanbuskirk
  • Medicine
  • American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
  • 2007
...
1
2
...